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(PC) epitopes involved the activation of Ag-specific B
cell clones of MZ and B1 B cell origin (Martin et al.,
2001). These studies, together with recent reports of
targeted mutations that affect MZ and B1 B cell develop-
ment and function, implicate these B cell compartments
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In contrast to TD responses, where T-DC cell interac-
tions are necessary for efficient B cell effector re-
sponses, no such accessory “helper” cells have beenSummary
described in TI immune reactions. In vitro generated DC
have been shown to influence in vitro B cell proliferation,Marginal zone (MZ) and B1 B lymphocytes participate
jointly in the early immune response against T-inde- isotype switching, and plasma cell differentiation (Fay-
ette et al., 1998). However, a need for DC in TI responsespendent (TI) particulate antigens. Here we show that
blood-derived neutrophil granulocytes and CD11clo was first suggested by the topographical association
and bidirectional expansion of spleen “myeloid” DC andimmature dendritic cells (DC) are the primary cells that
efficiently capture and transport particulate bacteria plasmablasts in response to a soluble TI Ag (Garcia de
Vinuesa et al., 1999). Additionally, it was shown recentlyto the spleen. In a systemic infection, CD11clo DC, but
not neutrophils, provide critical survival signals, which that in vitro generated, bone marrow-derived DC
(BMDC) support TI antibody secretion (Colino et al.,can be inhibited by TACI-Fc, to antigen-specific MZ B
cells and promote their differentiation into IgM-secre- 2002). Collectively, these results, showing that TI re-
sponses develop rapidly and generate large amountsting plasmablasts. In a local TI response, peritoneal
cavity macrophages provide similar support to B1 of IgM from a massive plasmablast pool, suggest a role
for dendritic cells in the process leading to plasma cellB-derived Ag-specific blasts. In the absence of soluble
TACI ligands, Ag-activated MZ- and B1-derived blasts differentiation. However, the identity of the cell type(s)
involved, and the cellular and molecular interactions inlack survival signals and undergo apoptosis, resulting
in severely impaired antibody responses. vivo that influence Ag-specific plasma cell generation,
are not known.
Here, we describe the capture and transport of Ag toIntroduction
the spleen by blood-derived, CD11clo DC, which are
singularly responsible for initiating and supporting theWhen bacterial pathogens enter a vertebrate organism,
orchestrated activities of a variety of effector cells and TI immune response. We also provide insight to the in
vivo molecular mechanisms involved in the DC-medi-molecules attempt their elimination. Immediately, innate
components, including neutrophil granulocytes, macro- ated B cell response. Recently described members of
the TNF superfamily, BLyS (B lymphocyte Stimulator,phages, dendritic cells, and complement and circulating
natural antibodies act in concert to effectively eliminate also called BAFF) and APRIL (A PRoliferation-Inducing
Ligand) are derived from monocyte/macrophages, DC,most of the circulating antigen (Ag). Subsequent to this
early phase, repetitive antigenic epitopes exposed on and subsets of T cells. Their receptors (TACI [Trans-
membrane Activator and Calcium modulator cyclophilinthe surface of pathogens activate Ag-specific B lympho-
cytes, which in the absence of T cells initiate a rapid ligand Interactor], BCMA [B Cell Maturation Antigen],
and BAFF-R, which is specific for BLyS/BAFF) haveT-independent (TI) immune response.
In contrast to the large body of work detailing the been suggested to provide survival signals for the B cell
lineage during development and activation (reviewed incellular and molecular events in T-dependent (TD) re-
sponses, little is known about the cellular and molecular MacKay and Browning, 2002). We show that these DC-
derived soluble ligands (BLyS and APRIL) bind to theirrequirements of a TI immune response. In addition, most
of the experimental systems used conventional soluble B cell receptor(s) and provide a crucial cosignal required
for plasma cell generation in TI immune responses.“laboratory” Ag to describe the precursor B cell types,
cellular kinetics, and topographical location of plasma
cells participating in TI as well as TD responses (Liu et Results
al., 1991; Jacob and Kelsoe, 1992; Toellner et al., 1996).
These types of molecules do not entirely mimic the real- Ag-Specific MZ B Cells Interact with CD11c Dendritic
ity of antigen, normally exposed on bacterial surfaces. Cells at the Site of Plasma Cell Differentiation
In order to understand the mechanisms that make the In order to trace Ag-specific B cell clones after TI B cell
spleen critical for effective protection against blood- activation, we utilized the M167, heavy chain transgenic
borne pathogens, we analyzed the early immune re- (Tg) mouse (VH1 heavy chain derived from the anti-PC
sponse to intact bacteria as a particulate Ag. We showed hybridoma M167). In this model the dominant B cell
that the ensuing response to surface phosphorylcholine clone, VH1-V24, reactive with PC, is enriched in the MZ
B cell subset (CD21hiIgMhiCD23loIgDlo) and located pre-
dominantly in the MZ. 24 hr after i.v. administration of3 Correspondence: john.kearney@ccc.uab.edu
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Figure 1. TI Ag-Specific B Cells Associate with Ag-Loaded Dendritic Cells at Sites of Plasmablast Differentiation
(A) Histology of the spleen from an unimmunized M167 mouse, stained with IgM (blue), M167 Id (red), and CD11c (green). Purple (red and
blue) Id B cells are enriched in the MZ.
(B) M167 mice, immunized with S. pneumoniae, were sacrificed at day 1 after i.v. immunization. Ag-specific B cells (purple; M167-Id red and
IgM blue) have migrated from the MZ to the T-B border and bridging channels (B1) that connect the white and red pulp, where they are
blasting in physical association with DC (CD11c, green; B1 and B2). Ag-specific Id cells enlarge and become brighter for intracellular
immunoglobulin (plasmablasts).
(C and D) In the same M167 mice at day 1 after immunization, spleen macrophages (F4/80, green, C) and neutrophil granulocytes (Gr-1, green,
D) do not participate in these primary B cell clusters stained with M167-Id (red) and IgM (blue).
(E and F) C57BL/6 (E) or T cell/ (F) mice adoptively transferred with M167 B cells and immunized with bacteria i.v. were sacrificed and
stained with IgM (blue), M167-Id (red), and CD11c (green) at day 1. Ag-driven migration and association with DC occurred regardless of the
presence (M167→C57BL/6; E) or absence of T cells (M167→T cell/; F).
(G) A functional triad composed of MZ derived B blasts (M167-Id, blue) and green bacteria taken up in vivo by DC (CD11c, red) is formed in
the bridging channels.
PC-bearing, heat-killed Streptococcus pneumoniae Myeloid Subsets Stimulate Ag-Specific Plasmablast
Differentiation In Vitro(henceforth referred to as “bacteria”), Ag-specific B cells
had moved from the MZ to the T-B border and bridging To identify the cellular requirements for the in vitro sur-
vival and differentiation of Ag-specific MZ B cells, wechannels that connect between the white and red pulp
(Figure 1A), and were blasting in physical association cocultured M167 B220 B cells for 3 days with various
unprimed or in vitro bacteria-primed myeloid subsets.with CD11c-expressing DC in the bridging channels (Fig-
ures 1B1 and 1B2). No other myeloid cells (Gr-1 granu- Coculture of Ag-specific B cells with in vitro bacteria-
primed bone marrow-derived dendritic cells (BMDC) re-locytes, F4/80 red pulp macrophages, or the MOMA-1
and ER-TR-9 splenic specialized macrophages) were sulted in a large-scale generation of Ag-specific plas-
mablasts (Syn-1hiIgMhiIdhi, Figure 2A). Although the lowfound in the primary clusters (Figures 1C–1D and data
not shown). The plasmablast production in the bridging viability (2%), seen with B cells alone or B cells plus
free bacteria, improved to 30% by the inclusion ofchannels continues until day 3–4, generating large num-
bers of plasmablasts. When very large numbers of Ag- “empty” BMDC, Ag-specific plasmablasts differentiated
only in the presence of primed BMDC (Figure 2A). De-specific B cells were transferred in transfer experiments
or in transgenic animals, cells from the T-B border form spite the fact that these cytokine-dependent, in vitro
generated BMDC were highly effective in vitro, their inT-less germinal centers as previously described (data
not shown; de Vinuesa et al., 2000; Martin and Kearney, vivo counterparts have not yet been identified. We also
found that primed, but not empty, total peritoneal cells2000a). To determine whether these events, including
the interactions with DC, occurred in the absence of T or FACS-sorted peritoneal macrophages (PEC Mφ)
showed similar potent support in this in vitro systemcells, we adoptively transferred B220B cells from M167
mice to T cell-deficient (TcR/TcR/, Figure 1F) or (Figure 2B).
The use of this experimental model was prompted byC57BL/6 (Figure 1E) recipients 20 hr prior to i.v. immuni-
zation with bacteria. As in the intact mice, MZ B-derived the generation of the dominant T15 anti-PC plasmablast
clone (Claflin et al., 1974). We cultured total peritonealblasts were located at the bridging channels in contact
with DC, 24 hr after Ag challenge, regardless of the cavity cells, containing PEC Mφ and B1 B cells, from
normal BALB/c mice together with S. pneumoniae andpresence or absence of T cells (Figures 1E–1F). Fluores-
cent bacteria were used to confirm that the injected found effective support of PEC Mφ for B1 B cell differen-
tiation (data not shown).particulate Ag also colocalized at these sites of apparent
DC-B cell interaction (Figure 1G). Since the systemic immune response to blood-borne
bacteria, including plasma cell differentiation, takesThese findings suggested that the formation of a po-
tentially interactive triad composed of Ag, DC, and B place largely in the spleen, we determined whether
freshly isolated spleen DC could provide signals neededcells initiated the observed Ag-specific plasma cell gen-
eration at this site. for in vitro plasmablast generation. We sorted splenic
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these cells do not have a known in vivo counterpart
in the spleen and blood stream during a systemic TI
response to blood-borne bacteria. In addition, the clas-
sic CD11chi DC subpopulations, isolated from the
spleen, that are perfectly capable of stimulating T cells
(Maldonado-Lopez et al., 1999) failed to provide efficient
B cell cosignals, suggesting that a different cell subset
was involved in this process.
CD11clo Blood DC Capture and Transport Ag,
and Activate B cells
Since a variety of cells with defined costimulatory activ-
ity isolated from the spleen, where TI immune responses
take place, failed to efficiently support in vitro plasma-
blastogenesis, we revisited the in vivo time course of
cellular events following i.v. bacterial immunization. The
first cells with potential to scavenge and transport i.v.
injected bacteria are located in the blood, so we
searched for subpopulations of cells with these capabili-
ties. Analysis of myeloid cells at time points within the
first day after i.v. bacteria revealed an 8–10 fold influx
of neutrophil granulocytes (Gr-1hiMac-1hi, granular cells)
into the spleen in the first 15–60 min (Figure 3A). These
granulocytes had captured bacteria, and accumulated
mostly in the MZ and bridging channels (Figure 3A, his-
tology). In addition to granulocytes, the entire blood
compartment of CD11clo DC migrated into the spleenFigure 2. Myeloid Cells Support Ag-Specific Plasmablast Differenti-
ation In Vitro by 1 hr after i.v. immunization (Figure 3B). After 4 hr,
the depleted CD11clo population began to recover (notB220 B cells from M167 mice were cultured for three days in
media, alone, or with various combinations of bacteria and bone shown), and by day 1, complete recovery of blood and
marrow-derived DC (BMDC) (A), PEC macrophages (PEC Mφ; B), spleen myeloid subsets had occurred (Figure 3B). To
spleen Mac-1hiCD11chi DC, blood neutrophil granulocytes, or LPS directly visualize and enumerate the cell types with the
(20 g/ml) (C). Harvested cells were stained with IgMa-FITC, Synde-
ability to capture intact bacteria, i.v. immunizations werecan-1-PE (Syn-1), and M167-Id, developed with SA-APC. Plots show
performed with fluorescent bacteria. We also found thatSyn-1 and M167-Id profiles of B cells, previously gated on IgMa
most bacteria were taken up by blood neutrophils, whichpopulations. Numbers indicate percentages of Ag-specific Syn-1
expressing plasmablasts of total IgMa cells. FACS profiles show migrated into the spleen within the first few hours after
one representative experiment of 3–15 for each condition. Ag introduction (Figures 3A, 3C, and 3D). In addition to
the neutrophils, blood CD11clo DC also captured antigen
and migrated from the blood into the spleen (Figures
3B–3D). Neither of the splenic resident DC subsetsCD11chiMac-1neg and CD11chiMac-1hi DC (commonly
termed “lymphoid” and “myeloid” DC, respectively), (CD11chiMac-1hi or CD11chiMac-1neg) appeared to have
access to the bacteria in vivo at these time points (Figureprimed them with bacteria, and cultured them with M167
B cells. Neither unprimed nor primed splenic CD11chi- 3D). To further dissect the antigen-handling capability
of these myeloid subsets, an in vitro phagocytosis assayMac-1neg DC supported the differentiation of Ag-specific
MZ B cells in 3-day cultures (data not shown). Although was performed using fluorescent bacteria and magneti-
cally enriched Mac-1 splenocytes. The three subsetsMZ B cells survived better in the case of primed spleen
CD11chiMac-1hi DC (25%) than unprimed (10%), plasma- examined showed similar uptake of bacteria in vitro (Fig-
ure 3E, black lines). However, trypan blue treatment,blasts were not generated (Figure 2C). Increased B cell
viability was very likely due to nonspecific stimulatory sig- which quenches fluorescence of surface, but not intra-
cellular particles, pinpointed that CD11clo as well asnals derived from bacteria-activated DC (Kadowaki et
al., 2001). Similarly, coculture with primed spleen Mφ Mac-1hi cells (including neutrophils and macrophages),
but not CD11chi DC, successfully internalized the bacte-(Mac-1hi excluding DC and granulocytes) enhanced the
B cell survival without supporting strong plasmablast ria (Figure 3E, colored filled histograms).
The cells expressing low levels of CD11c were Mac-differentiation (not shown). In addition, FACS-sorted,
bacteria-primed neutrophil granulocytes (Gr-1hiMac-1hi 1hi and were negative for CD4, CD8 and B220. They
also expressed high levels of B7.1 and CD43, low levelsCD11c) did not promote survival of Ag-specific B cells
(Figure 2C). Polyclonal B cell stimulation with LPS for 3 of Gr-1, B7.2 and CD40 and very low levels of MHC class
II (Figure 3F and not shown). In addition to capturingdays generated only a minor population of Id plas-
mablasts, proportional to the initial representation of Id bacteria and migrating from blood into the spleen, these
blood DC displayed upregulated activation markers 6MZ B cells in the culture (Figure 2C).
These results showed that selected populations of hr after bacterial uptake (Figure 3F). Treatment of FACS
sorted blood-derived CD11clo DC with GM-CSF for 24macrophages (PEC Mφ) and in vitro-generated BMDC
participate as supporting cells in TI responses. However, hr induced upregulation of CD11c, class II, B7.1 and
Immunity
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Figure 3. Blood-Derived Neutrophils and CD11clo DC Capture and Transport Ag to the Spleen
(A and B) Neutrophil granulocytes (A) and CD11clo DC (B) rapidly migrate from the blood into the spleen following i.v. bacterial immunization.
C57BL/6 mice were injected with S. pneumoniae and sacrificed, and splenocytes were stained with Mac-1, CD11c, and Gr-1 at different time
points. Numbers represent total cells out of 250,000 live splenocytes falling into the appropriate gates. Spleen sections were stained with
antibodies against IgM (blue) and Gr-1 (green), while the fluorescent bacteria are red.
(C) Neutrophil granulocytes and CD11clo DC are the major subsets that capture intact bacteria in the blood. Peripheral blood from C57BL/6
mice 15 min after i.v. immunization with green fluorescent bacteria was stained with CD11c, Mac-1, and Gr-1 mAbs, and analyzed by FACS.
The green rectangular gate shows all cells with captured bacteria, and black and red gates represent bacteria-bearing neutrophils and CD11clo
DC, respectively.
(D) Neutrophil granulocytes and blood-derived CD11clo DC transport intact bacteria into the spleen, while resident splenic CD11chi DC do not
have access to bacteria in vivo at any time. C57BL/6 mice, injected with green fluorescent bacteria, were sacrificed 1 hour after i.v. immunization
and splenocytes stained with CD11c, Mac-1, and Gr-1 mAbs and analyzed by FACS. Numbers show percentages of bacteria-bearing cells
from each subset.
(E) Spleen Mac-1hiCD11cneg (granulocytes and macrophages [56 	 5%]) and CD11clo (30	3%), but not Mac-1hiCD11chi (3 	 1%), DC subsets
phagocytose intact bacteria in vitro. Splenocytes were enriched for Mac-1 and exposed in vitro to fluorescent bacteria. Black histograms
show green bacteria on the particular subsets; filled colored histograms represent surface (sf) versus intracellular (IC) bacteria after trypan
blue treatment.
(F) Blood-derived CD11clo cells represent the major DC population in the blood. They have low levels of class II and B7.2, and upregulate
activation markers upon bacterial uptake. Blood mononuclear cells were stained with CD11c, Mac-1, and different DC subset-specific and
activation markers. Bacteria-bearing CD11clo DC were phenotyped after 6 hours of i.v. immunization from the spleens of neutrophil granulocyte-
depleted C57BL/6 mice, immunized with green fluorescent bacteria. FACS-sorted blood-derived CD11clo DC were cultured with GM-CSF for
24 hr and phenotyped. Histograms show the resting phenotype of blood DC (empty) overlaid with bacteria-activated CD11clo DC (red filled)
and DC cultured with GM-CSF (blue filled).
All results are representative of 3 experiments with 3–5 mice in each group.
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Figure 4. Bacteria-Primed Blood-Derived CD11clo DC Support Naı¨ve MZ B Cells to Differentiate into Plasmablasts
(A) In vivo depletion of neutrophil granulocytes results in enrichment of bacteria-capturing CD11clo DC. Untreated or anti-Gr-1 mAb treated
C57BL/6 mice were immunized with green fluorescent bacteria and analyzed at 4 hours after bacterial challenge. Sections were stained with
antibodies against CD11c (red) and Gr-1 and ER-TR-9 recognizing MZM (Marginal Zone Macrophages) (both subsets are blue).
(B) CD11clo DC from spleens of neutrophil-depleted mice, 4 hours after in vivo bacteria-priming or blood-derived in vitro bacteria-primed
CD11clo DC were cultured with B cells from M167 mice for 3 days and stained for IgMa, Syn-1, and M167-Id. Profiles show IgMa gated cells
and the numbers represent the percentage of cells with plasmablast (M167Syn-1) phenotype. Cytospins of primed DC were stained with
CD11c (red), followed by nuclear DAPI counterstaining (blue), while the bacteria are green. Profiles are representative of 3 experiments.
B7.2 molecules, but not of B220 and Gr-1 (Figure 3F and the IFN-secreting plasmacytoid DC subset (Asselin-
Paturel et al., 2001); however, it did not affect the magni-not shown). Fresh sorted (as well as 2 hr LPS activated)
CD11clo blood derived cells were also potent as antigen tude or kinetics of the antibacterial immune response
(not shown). The absence of neutrophils enabled betterpresenting cells in a mixed lymphocyte reaction (not
shown). All these data suggest that CD11cloMac-1hi cells access of CD11clo DC to Ag in vivo (Figure 4A, left pan-
els), and the number of bacteria-bearing CD11clo DCbelong to the dendritic cell lineage and are exceptionally
proficient in blood-borne particulate antigen capture. was increased (Figure 4A, middle and right panels). To
determine the functional capabilities of these cells, weAlthough blood neutrophils were a major population
migrating into the spleen and were clearly efficient in cocultured M167 B220 B cells with FACS-sorted, in
vivo-primed, or empty CD11clo DC from these neutrophilthe phagocytosis and transport of bacteria in this model,
they failed to support survival and differentiation of plas- granulocyte-depleted mice. In the same in vitro system,
we tested the supporting ability of FACS-sorted blood-mablasts in the previously described in vitro culture sys-
tem (Figure 2C). derived CD11clo DC after in vitro bacterial priming. Only
in vivo- or in vitro-primed, but not empty, CD11clo DCTemporary removal of neutrophils by in vivo anti-Gr-1
mAb treatment was used to enrich and facilitate the promoted the generation of Syndecan-1 Ag-specific
plasmablasts from naı¨ve MZ B cells in vitro (Figure 4B).analysis of the small numbers of CD11clo DC cells in the
blood, prior to immunization with fluorescent bacteria. In Taken together, these data showed that blood-derived
CD11clo DC play a necessary and sufficient role in theaddition to neutrophils, the Gr-1 treatment also depletes
Immunity
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Figure 5. TI Ag-Specific Plasmablast Differ-
entiation Requires DC Derived Soluble Fac-
tors and Is Inhibited by TACI-Fc In Vitro
(A) In vitro bacteria-primed PEC cells were
pretreated with TACI-Fc fusion protein in de-
creasing concentrations for 30’ at 37
C; B220
B cells from M167 mice were added and cul-
tured for 3 days. Profiles are representative
of 3 independent experiments.
(B) Soluble factors from in vitro-primed PEC,
but not membrane molecules, provide the
signals for Ag-specific plasmablast differenti-
ation. PEC cells from C57BL/6 mice were cul-
tured for 3 days with intact S. pneumoniae.
SNs were harvested and filtered and cells
were irradiated with 2500 cG. SNs and the
irradiated cells were cultured with M167
B220 B cells for 3 days and analyzed by
FACS, as described above. Profiles are repre-
sentative of 3 independent experiments.
(C) SN from bacteria-primed blood-derived CD11clo DC support Ag-specific plasmablast generation. CD11clo DC, FACS-sorted from blood,
were cultured with bacteria, LPS, or media for 3 days. SNs were harvested and cocultured with M167 B220 B cells for a further 3 days,
stained, and analyzed by FACS as describe above. Profiles show one representative of 3 independent experiments.
initiation of a TI immune response against blood-borne g/ml) of circulating TACI-Fc were obtained as early as
2 days after viral administration (not shown).S. pneumoniae.
High and low doses, 2 109 and 2 108 viral particles/
mouse, of TACI-Ad inhibited the differentiation ofTI Ag-Specific Plasmablast Differentiation Is Inhibited
splenic Ag-specific plasmablasts at 3 days after immuni-by TACI-Fc Treatment In Vitro
zation by 75% and 50%, respectively. Control virusHaving identified the functionally relevant accessory
(LacZ-Ad) treatment did not affect the anti-PC immunecells involved in TI plasma cell differentiation, we next
response (Figure 6A). This short-term treatment of TACI-wished to determine the molecular mechanisms of this
Ad selectively affected only the Ag-activated Id MZ BDC-B cell interaction. We analyzed the effect of TACI-
cells, leaving non Ag-specific, bystander follicular andFc, which effectively blocks BLyS and APRIL binding to
Id MZ B cells unaltered (Figure 6A, graph).their respective receptors on B cells. In cultures of M167
To determine whether the observed reduction inB220 B cells and PEC-supportive cells, TACI-Fc, but
plasma cell numbers by day 3 reflected a different kinet-not a control LFA-3-Fc, inhibited the differentiation of naı¨ve
ics of differentiation, we analyzed the time course ofMZ B cells into Ag-specific plasmablasts in a dose-depen-
the response of adoptively transferred M167 B cells indent manner (Figure 5A). To analyze whether soluble
C57BL/6 recipients. At each time point, Ag-specific Bligands or membrane contact between supporting cells
cell numbers in TACI-Ad treated mice were increasinglyand B lymphocytes would induce the B cell differentia-
reduced as the immune response progressed comparedtion, conditioned supernatant (SN) from PEC Mφ cultured
to the response in control virus groups (Figure 6B).with bacteria for 3 days, or bacteria-loaded, irradiated PEC
In normal, nontransgenic mice, the antibody response
Mφ, were added to M167 B220 B cells. As seen in
to PC is the net result of a major B1 and a minor MZ B
Figure 5B, Ag-specific plasmablasts were generated in
cell derived component. To determine whether soluble
the presence of conditioned SN, but not with irradiated, TACI-ligands were also crucial for the differentiation of
bacteria-loaded PEC Mφ. The supportive effect of the plasma cells from B1 B precursors, we immunized nor-
SN was blocked entirely by TACI-Fc added to the culture mal BALB/c mice i.v. and i.p. following TACI-Ad and
media (not shown). Similarly, successful plasmablast control virus injection. In BALB/c mice, B1 B cells are
generation occurred when we used day 3 SNs from normally responsible for 85% of the anti-PC response
FACS-sorted, blood-derived bacteria-primed CD11clo (Martin et al., 2001). The inhibition of plasma cell genera-
DC (Figure 5C). As a control, SN from LPS-stimulated tion in the spleen after TACI-Ad treatment was similar
CD11clo DC supported polyclonal expansion; however, to that observed when the response was entirely derived
in this case, the Id subset did not dominate the culture. from transgenic MZ B cells, and occurred with both i.v.
These data showed that TACI-ligands secreted by and i.p. immunizations (Figure 6C).
supporting cells provided a necessary and sufficient These results confirmed in vivo that the major effect
cosignal to Ag-specific MZ B cells to differentiate into of TACI-Fc was to block DC-B cell interactions in TI
plasmablasts in vitro. responses, and also highlighted the selectivity of short-
term TACI-Ad treatment for Ag-activated, but not by-
TI Ag-Specific Plasmablast Differentiation Is Reduced stander, B cells.
after In Vivo TACI-Fc-Adenovirus Treatment
To block in vivo the interaction between BLyS and APRIL Inhibition by TACI-Ad Treatment Is Due to Preferential
and their respective ligands, adenovirus-expressed Apoptosis of Ag-Activated MZ-Derived Blasts
TACI-Fc (TACI-Ad) was injected 2 days before immuniz- The TACI-Ad blockade of plasma cell generation may
have been due to an effect on Ag-specific MZ B celling with bacteria. Using this protocol, high levels (50–100
Figure 6. TI Ag-Specific Plasmablast Differentiation Is Diminished after TACI-Ad Treatment In Vivo
(A) M167 mice injected with TACI-Ad or control virus (LacZ-Ad) were immunized with S. pneumoniae, sacrificed at day 3 after bacterial
challenge, and stained with antibodies against IgMa, M167-Id, and Syn-1 for FACS analysis. Profiles show splenocytes gated on IgMa
population. Graph displays changes in Ag-specific plasma cell (Syn-1hiIdhi), total Ag-specific B cell (IgMId), and non-Ag-specific B cell
(IgMId) compartments after Ad treatments compared to the regular immune response (no virus treatment).
(B) 2 106 MACS-purified M167 B220 B cells were injected into TACI-Ad and control virus-treated C57BL/6 recipients, which were immunized
with bacteria 24 hours later. Mice were sacrificed at days 2, 3, and 6. Transferred Ag-specific MZ B cells were followed by staining for IgMa
and M167-Id. Sections from the same mice were stained with IgMb (green), M167-Id (red), and IBL-7/1 (blue). Graph shows absolute numbers
of Ag-specific plasma cells (IgMM167-IdhiSyn-1hi) through the first 6 days of the response.
(C) BALB/c mice injected with TACI-Ad and control virus were sacrificed at 3 days after i.v. or i.p. bacterial immunization. Spleen cells were
stained with PC and mAbs against Syn-1 and T15 idiotype (AB1.2).
Profiles are representative of two experiments with 4–5 mice in each group.
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Figure 7. Ag-Specific MZ-Derived Blasts Undergoing Preferential Apoptosis in the Presence of Circulating TACI-Fc Can Be Rescued by
Constitutive Expression of bcl-2 in B Cells
(A) 2  106 CMFDA-labeled splenocytes were injected into TACI-Ad and control virus-treated C57BL/6 recipients, which were immunized with
S. pneumoniae after 24 hours. Recipients were sacrificed at days 2 and 3 and spleen cells were stained with antibodies against IgMa and
M167-Id.
(B) TACI-Ad and control virus-treated M167 mice were sacrificed at day 2 after bacterial immunization, and spleen cells were stained for
Syn-1, TUNEL, cytoplasmic IgM, and M167-Id. Plots show TUNEL levels on total plasma cells (Syn-1hi and cytoplasmic IgMhi gated). Profiles
are representative of three mice in each group.
(C) B1 B cell-derived anti-PC plasma numbers were rescued from the blocking effects of TACI-Fc by forced expression of bcl-2 in B cells.
TACI-Ad and control virus-treated bcl-2 Tg C57BL/6 and non-Tg littermate mice were immunized with bacteria and sacrificed at day 3. Graph
shows percentage of anti-PC immune response in TACI-Ad-treated groups compared to the control virus (n  4).
(D) The MZ B cell-derived anti-PC response was rescued by bcl-2 transgenic expression. 2  106 M167 bcl-2 double Tg and M167 littermate
splenocytes (containing 5  103 M167 Id MZ B cells) and 107 filler cells were transferred into TACI-Ad and control virus-treated C57BL/6
recipients, which were immunized with bacteria. Recipients were sacrificed at 3 days after bacterial challenge and spleen cells were stained
with PC and mAbs against Syn-1, M167, and T15 idiotypes. Sections from the same mice were stained with antibodies against T15 Id (green),
M167-Id (red), and IBL-7/1 (blue). Graph displays percentages of anti-PC immune responses, constituted by two dominant B cell clones (T15
and M167), in TACI-Ad compared to the control virus-treated groups. Profiles are representative of 4 mice in each group.
Requirements of TI Plasma Cell Differentiation
349
proliferation or alternatively on B cell survival. To deter- primary clusters of MZ B cell-derived blasts in the bridg-
ing channels of the spleen (Figure 1). These blood-mine whether the inhibition of plasma cell differentiation
resulted from arrested proliferation, CMFDA-labeled derived DC appeared to be the only DC subset in this
system with a significant capacity to capture and trans-M167 B220B cells were transferred into C57BL/6 recip-
ients previously injected with TACI-Ad or control virus. port intact bacteria to the spleen in the first few hours
after i.v. immunization (Figure 3). This support, both inNo striking differences in the CMFDA levels in Ag-spe-
cific B cells were found at day 2 or 3 after immunization vitro and in vivo, depended on critical interactions of
TACI-ligands with their receptors on MZ and B1 B cells,(Figure 7A), indicating that the reduction in plasmablast
numbers was not correlated with a major decrease in respectively (Figures 5 and 6). It was previously shown
that BLyS signaled the upregulation of survival genesproliferation. At all time points, Id B cells remained
nonactivated, while Ag-specific MZ-derived blasts di- (bcl-2, bcl-XL) (Do et al., 2000), and here we provide
direct in vivo evidence that constitutive overexpressionluted the CMFDA equally in both control and TACI-Ad
treated mice. of bcl-2 rescues plasmablasts from the blocking effects
of TACI-Ad treatment.We next determined, by TUNEL staining of spleen
cells from TACI-Ad injected M167 Tg mice 2 days after The seemingly unique functional ability of blood-
derived DC to initiate the TI immune response is likelyimmunization, if the decreased plasmablast numbers
were due to increased cell death. We found that there due to their increased ability to phagocytose and mi-
grate (Figure 2E). Early work has clearly shown myeloid/was a 4- to 5-fold increase in apoptosis, which occurred
preferentially in the Ag-specific plasmablast compart- dendritic cells migrating from the bone marrow to the
site of inflammatory injury (Oghiso et al., 1992).ment, after TACI-Ad treatment compared to the control
virus-treated groups (Figure 7B). CD11cMac-1Ly6C preimmunocytes were detected
in bone marrow and blood, and gave rise to all matureThe upregulation of survival-associated genes is com-
mon during lymphocyte activation, permitting the fa- DC subsets and macrophages (Bruno et al., 2001). Also,
recent reports have identified immediate precursors forvored clone to expand or differentiate further and form
effector cell types (Carey et al., 2000). We next asked mouse mature DC subsets, characterized by CD11c
and various levels of B220, Gr-1, Mac-1, and CD4 (delwhether constitutive overexpression of the antiapo-
ptotic gene, bcl-2, would counteract the effect of TACI- Hoyo et al., 2002; Asselin-Paturel et al., 2001; Shortman
and Liu, 2002). Splenic CD11cloMac-1hi DC have beenAd on plasmablast differentiationm and we immunized
bcl-2 Tg mice with bacteria after TACI-Ad pretreatment. described (Daro et al., 2000), but their functional poten-
tial in immune responses was not evaluated. The out-As a readout for the effects of bcl-2 on TACI-Fc inhibi-
tion, B1-derived (T15 clone) plasmablasts were analyzed standing attribute of these DC seems to be their initial
access to blood-borne Ag, due to their presence in theat day 3.5 after immunization. Enforced bcl-2 expression
fully rescued the anti-PC plasmablast compartment, blood stream. These studies raise questions regarding
the function of these blood DC. What are the molecularsuggesting that an antiapoptotic signal was a major
component of the differentiation process blocked by mechanisms permitting this efficient antigen capture,
and what is the basis for their superiority over other DCTACI-Fc (Figure 7C). To determine if TACI-Ad treatment
inhibited MZ-derived plasma cell differentiation by a subsets in providing B cell help? Since these DC have
greater accessibility than organ-associated DC tosimilar mechanism to that shown for B1 cells, limited
numbers of M167/bcl-2 double Tg B cells were trans- blood-borne antigens, it is very likely that they are part
of the first line of innate defense mechanisms involvedferred into TACI-Ad or control virus-injected C57BL/6
recipients. Plasmablasts were assayed at day 3 after in the capture and presentation of antigen to MZ and
B1 B cells.immunization. In this transfer experiment, the anti-PC
plasmablast pool in the recipient is composed of donor- The molecular basis of this DC-B cell interaction ap-
pears to be complex, since it involves at least threederived MZ B cells, expressing the bcl-2 Tg and recipi-
ent-derived wild-type B1 B cells, without the bcl-2 Tg. receptors (BCMA, TACI, BAFF-R) and 2 ligands (BLyS,
APRIL). In several other reports, similar to our data, aAs seen in Figure 7D, donor MZ (M167/bcl-2 Tg), but
not endogenous B1 B-derived (T15), plasmablasts were partial reduction of antibody levels occurred in both TI
(NP-Ficoll, Pneumovax) and TD (NP-CGG, etc) re-rescued in the same TACI-Ad treated hosts. The immune
response in all bcl-2 Tg mice was slightly reduced com- sponses (Yan et al., 2001; von Bulow et al., 2001). Al-
though previous studies in TACI/ mice suggested thatpared to non-Tg littermates, most likely due to the partial
inhibition of proliferation by the constitutive hyperex- this molecule was involved in TI responses, these results
(von Bulow et al., 2001) are puzzling, since there werepression of bcl-2 in B cells (O’Reilly et al., 1997).
These results showed a requirement for a survival marked alterations in B cell numbers and the appear-
signal received from TACI-ligands for both MZ and B1 ance of hyperresponsive B cells (Yan et al., 2001). A
B cell compartments involved in TI responses. constant higher level of responsiveness may have re-
sulted in the exhaustion of precursor subsets responsi-
ble for TI responses. We have readdressed this problem,Discussion
using a model in which Ag-specific B cells are normal,
the blocking is done in real time, and the Ag-reactive BWe have identified the cellular participants and the mo-
lecular interactions required for the Ag-specific plas- cell clones were traced throughout the activation period.
mablast differentiation that occur early in the TI immune A possible explanation for the partial inhibition with
response against blood-borne particulate Ag. DC and TACI-Fc treatment is the existence of an as yet unde-
B cells, but not other myeloid cells, were found in the fined ligand/receptor pair, which was not blocked in
Immunity
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oratories (Bar Harbor, ME). T-C57BL/6 and bcl-2 Tg (C57BL/6-TgNthese experiments. Future use of receptor-specific an-
(BCL2) 22Wehi) mice (gift of M.D. Cooper, UAB, Birmingham, AL)tagonists will distinguish between the individual roles
were bred with M167-C57BL/6 (gift of Dr. J.J. Kenny, NIH, Washing-of each ligand/receptor pair in TI activation.
ton, DC).
Long-term (2 weeks) absence of circulating BLyS
leads to the loss of almost the entire mature B cell Adoptive Transfer and CMFDA Labeling
compartment (Schiemann et al., 2001; Schneider et al., 2  106 /injection of M167 splenocytes (in some cases labeled with
2001). Likewise, long-term TACI-Fc treatment leads to CMFDA as described earlier [Martin and Kearney, 2000b]) were
adoptively transferred into C57BL/6 recipients, followed by i.v. im-the loss of B cells, although it is crucial to note that
munization. Mice were sacrificed and analyzed at day 2 and 3. Forshort-term (within the first six days) administration of
earlier time points, 20–40  106 magnetically sorted M167 B220TACI-Ad affected mostly Ag-activated B cells (Figure
cells were transferred into T cell/ or C57BL/6 mice and analyzed6A). That B cells in various stages of activation exhibit at day 1.
differential sensitivity to blocking effects on this path-
way is crucial, and might provide possible therapeutic Immunizations
manipulation of immune responses and autoimmunity. 8- to 12-week-old mice were immunized i.v. or i.p. with 108 heat-
It is likely that blockade of TACI will inhibit at least the killed, pepsin-treated S. pneumoniae (strain R36A) (Briles et al.,
1981) per injection. To track Ag uptake in vivo, S. pneumoniae wereTI component in certain pathological immune re-
conjugated with Alexa-488 (Molecular Probes, Eugene, OR) ac-sponses. In addition, the resolution of the role that APRIL
cording to the manufacturer’s protocol. Ag-specific B cells wereand its receptors play in this reaction is of interest for
identified and traced using a monoclonal anti-idiotypic Ab (M167
alternative therapeutic manipulations. Id) or with labeled Ag (PC). Mice were analyzed at various time
DC have been previously suggested to facilitate B points (1, 4, and 8 hr; days 1, 2, 3, and 6).
cell functions; however, most of these studies did not
directly survey Ag-specific B cell activation. DC were Flow Cytometry and Cell Sorting
FITC-mAbs specific for mouse CD11c, PE-mAbs recognizing mousesuggested to transport and transfer antigen to naı¨ve B
markers (CD11c, Syndecan-1, CD11b, CD43), biotinylated mAbslymphocytes in initiating and modifying TD responses
specific for mouse antigens (CD11c, CD4, CD8, CD80, CD86, CD40,(Wykes et al., 1998; Fayette et al., 1998). In other mouse
CD1, CD44, CD62L, Gr-1, B220), and Streptavidin-APC were pur-models, the use of in vitro generated BMDC also sug-
chased from PharMingen (San Diego, CA). Goat anti-mouse IgM-
gested a need for DC in B cell activation (Colino et al., Cy5 was purchased from Jackson Immunoresearch Inc. (West
2002), or the in situ association of DC with TI plas- Grove, PA). PC-Dex-FITC and anti-M167-PE and biotin were a gift
mablasts (Garcia de Vinuesa et al., 1999). However, our from Dr. Jim Kenny (NIH, Washington, DC). AB1.2-Alexa-488 (anti-
T15 Id), anti-Igh6a (RS3.1-Alexa-488), and anti-Igh6b (MB.86-Alexa-work defines a DC subset, derived contemporaneously
488) were described (Martin et al., 2001). Three- and four-colorwith the in vivo introduction of Ag, that promotes Ag-
surface staining and analysis was performed as previously de-specific plasma cell differentiation in vitro and in vivo.
scribed (Martin et al., 2001). TUNEL was performed using a Fluores-These findings raise further questions related to T de- cein-labeled In Situ Cell Death Detection Kit (Roche Diagnostics
pendent immune responses. Is the DC-B cell interaction Corporation, Indianapolis, IN).
we have described a normal component of the primary To sort Mac-1hiCD11clo, Mac-1hiCD11chi, Mac-1hiCD11neg, and Mac-
TD immune response, in which DC-B cell communica- 1hiGr-1hi cells, splenocytes (from 20–40 mice) or blood mononuclear
fraction (from 70–120 mice) were magnetically enriched for Mac-1tions may occur in the extrafollicular reaction, in addition
and stained with CD11c-FITC, Mac-1-PE, and Gr-1-biotin mAbs.to the T-DC and T-B interactions? Additionally, do Mac-
CD11chiMac-1neg cells were sorted from spleens magnetically en-1CD11c pre-immunocytes in the bone marrow (Bruno
riched for CD11c, stained with CD11c-FITC and Mac-1-PE mAbs.
et al., 2001) play a supportive role in the survival of long- In vivo-primed CD11clo DC were obtained from 20–25 spleens from
lived plasma cells associated with TD immune re- mice treated with anti-Gr-1 mAb 24 hr prior to immunization with
sponses? Alexa-488-S. pneumoniae. Cells were sorted with a FACStar Plus
Infiltrating cells exhibiting a MZ B cell phenotype have (Becton Dickinson, Mountain View, CA) or a MoFlo (Cytomation, Ft.
Collins, CO).been recently described in two distinct, organ-specific
autoimmune diseases, involving the thyroid gland in
Immunofluorescence on Tissue SectionsGraves’ disease and the salivary gland in Sjogren’s syn-
Tissue sections were processed and analyzed as described (Martindrome (Segundo et al., 2001; Groom et al., 2002). Higher
et al., 2001). Frozen sections were stained with a cocktail of AMCA-levels of circulating BLyS were also found in patients
goat-anti-IgM (Vector Laboratories, Burlingame, CA) and PE-M167
with SLE and Sjogren’s syndrome (Zhang et al., 2001; and either anti-CD11c or Gr-1 or F4/80 (Caltag, Sac Francisco, CA)
Groom et al., 2002). It is likely that DC, by providing conjugated with biotin. After washing, biotinylated Abs were devel-
constant high levels of soluble TACI ligands, sustain oped with Streptavidin-Alexa 488 (Molecular Probes, Eugene, OR).
When Alexa-488 labeled bacteria were traced, we stained the sec-pathological B cell activation and survival, characteristic
tions with ER-TR-9 (generous gift from Dr. Georg Kraal, specific forof these diseases. Our observation that their short-term
mouse splenic MZ macrophages) and anti-Gr-1 mAbs, both devel-in vivo blockade preferentially targets the TI Ag-acti-
oped with goat anti-rat Ig-AMCA (Jackson Immunoresearch Inc,vated B cell compartment also suggests rational thera- West Grove, PA), blocked with normal rat serum (Peel-Freeze, Rog-
peutic approaches to autoimmune diseases. ers, AR), washed, and stained with PE-CD11c. When staining for
Finally, the versatile, Ag-capturing capabilities of the plasma cells, we stained the sections with a cocktail of biotinylated
blood DC described here make them ideal candidates IBL-7/1 (recognizes marginal sinus and red pulp endothelium, Ba-
lazs et al., 1999), PE-M167, and either AB1.2-Alexa-488 or FITC-as targets to deliver particulate packaged therapeutic
anti-Igh6b. Biotinylated Ab was developed with Streptavidin-AMCAcompounds.
(Vector Laboratories, Burlingame, CA).
Experimental procedures
Magnetic Cell Sorting
To enrich for spleen DC cells, typically 5–10 C57BL/6 spleens wereAnimals
incubated with anti-CD11c magnetic beads (Miltenyi Biotec, Auburn,8- to 12-week-old C57BL/6, BALB/c, T-C57BL/6, T cell/
(TcR/TcR/) C57BL/6 mice were purchased from Jackson Lab- CA), followed by double positive selection on an AutoMACS (Miltenyi
Requirements of TI Plasma Cell Differentiation
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Biotec, Auburn, CA). When isolating CD11clo cells, enrichment for and Fas-mediated signals for life and death. Immunol. Rev. 176,
105–115.Mac-1 cells with anti-CD11b magnetic beads and double positive
selection were performed. Mac-1hiCD11clo and CD11hi cells were Claflin, J.L., Lieberman, R., and Davie, J.M. (1974). Clonal nature of
then FACS sorted as described above. B220 cells from M167 trans- the immune response to phosphorylcholine. II. Idiotypic specificity
genic mice were obtained with greater than 96% purity using anti- and binding characteristics of anti-phosphorylcholine antibodies. J.
B220 beads and single or double positive selection. Immunol. 112, 1747–1756.
Colino, J., Shen, Y., and Snapper, C.M. (2002). Dendritic cells pulsed
In Vitro Cultures and Phagocytosis with intact Streptococcus pneumoniae elicit both protein- and poly-
2.5 105 M167 B220 cells were plated in 0.2 ml of complete RPMI saccharide-specific immunoglobulin isotype responses in vivo
1640 media in U-bottom tissue culture plates and cultured alone or through distinct mechanisms. J. Exp. Med. 195, 1–13.
with bacteria (106 /ml) or with LPS (20 g/ml) or with various myeloid
Daro, E., Pulendran, B., Brasel, K., Teepe, M., Pettit, D., Lynch, D.H.,cells (in 1:5 ratio to B cells), unprimed or previously primed (107
Vremec, D., Robb, L., Shortman, K., McKenna, H.J., et al. (2000).bacteria/106 cells, for 2 hr at 37
C). In blocking experiments, primed
Polyethylene glycol-modified GM-CSF expands CD11b(high)CD11-PEC cells were preincubated with 0.002–20 g/ml anti-human TACI-
c(high) but notCD11b(low)CD11c(high) murine dendritic cells in vivo:Fc (a gift from Human Genome Sciences) or 20 g/ml anti-human-
a comparative analysis with Flt3 ligand. J. Immunol. 165, 49–58.LFA-3-Fc (gift of Paul Rennert, Biogen, Cambridge, MA) for 30 min.
de Vinuesa, C.G., Cook, M.C., Ball, J., Drew, M., Sunners, Y., Cas-3-day supernatants were used from bacteria or LPS-primed FACS-
calho, M., Wabl, M., Klaus, G.G., and MacLennan, I.C. (2000). Germi-sorted blood CD11clo DC cells or PEC in cocultures with M167
nal centers without T cells. J. Exp. Med. 191, 485–494.B220 cells. After 72 hr, the cells were harvested, washed, and
used for FACS. Bone marrow-derived DC from C57BL/6 mice were del Hoyo, G.M., Martin, P., Vargas, H.H., Ruiz, S., Arias, C.F., and
generated as described (Inaba et al., 1992). FACS-sorted blood Ardavin, C. (2002). Characterization of a common precursor popula-
CD11clo cells were cultured with 100 U/ml GM-CSF (Immunex, Seat- tion for dendritic cells. Nature 415, 1043–1047.
tle, WA) for 24 hr and cells were used for FACS. Phagocytosis Do, R.K., Hatada, E., Lee, H., Tourigny, M.R., Hilbert, D., and Chen-
assays with and without trypan-blue were performed using Mac-1 Kiang, S. (2000). Attenuation of apoptosis underlies B lymphocyte
magnetically enriched splenocytes and gating on each subset (Ra- stimulator enhancement of humoral immune response. J. Exp. Med.
met et al., 2002). 192, 953–964.
Fayette, J., Durand, I., Bridon, J.M., Arpin, C., Dubois, B., Caux, C.,Construction of the Recombinant Adenoviral Vector
Liu, Y.J., Banchereau, J., and Briere, F. (1998). Dendritic cells en-Encoding TACI-Fc
hance the differentiation of naive B cells into plasma cells in vitro.A fusion gene construct was obtained from Human Genome Sci-
Scand. J. Immunol. 48, 563–570.ences, in which the extracellular domain of TACI was fused with the
Garcia de Vinuesa, C., Gulbranson-Judge, A., Khan, M., O’Leary,Fc portion of human IgG1. The cDNA was cloned into an adenoviral
P., Cascalho, M., Wabl, M., Klaus, G.G., Owen, M.J., and MacLen-shuttle vector from Quantum Biotechnologies, Inc. (Vancouver, Can-
nan, I.C. (1999). Dendritic cells associated with plasmablast survival.ada). The recombinant adenoviral vector was made by cotransfec-
Eur. J. Immunol. 29, 3712–3721.tion of 293 cells with the linearized shuttle vector containing the
TACI-Fc with a large fragment of the adenovirus DNA. Recombinant Groom, J., Kalled, S.L., Cutler, A.H., Olson, C., Woodcock, S.A.,
adenoviral vectors were screened by in situ immunofluorescent Schneider, P., Tschopp, J., Cachero, T.G., Batten, M., Wheway, J.,
staining of the plaques with anti-human IgG1 mAb (PharMingen, et al. (2002). Association of BAFF/BLyS overexpression and altered
San Diego, CA). B cell differentiation with Sjogren’s syndrome. J. Clin. Invest. 109,
59–68.
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